The Abdera Therapeutics team (courtesy Abdera)
Abdera raises $110M to push targeted radiotherapies where they haven’t gone before
Radiopharmaceutical biotech Abdera has raised $110 million in a Series B to get its first candidate into the clinic and build out its pipeline. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
